Position in TRVI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,044,786
-$278,283 QoQ
Shares Held
270,498
-39.4% QoQ
Ownership
0.190%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 216 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. TRVI ranks #146 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in TRVI
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,044,786 | 270,498 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $5,323,069 | 446,192 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $3,438,341 | 274,628 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $2,732,298 | 298,612 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,937,610 | 354,225 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $585,177 | 93,033 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $187,521 | 45,515 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $93,059 | 27,862 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $53,666 | 18,009 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $145,307 | 42,118 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $42,045 | 31,377 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $49,213 | 22,575 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $57,491 | 24,055 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $14,023 | 7,580 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,965 | 3,091 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $6,586 | 4,277 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $13,406 | 4,771 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $3,572 | 1,624 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $7,242 | 5,173 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,808 | 2,137 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $6,444 | 2,378 | Shares | Sole | 2021-05-12 | |
| 2020-03-31 | $1,779 | 541 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||